Summary
Tetrahydrobiopterin (BH4) is a pteridine product which is released by rodent macrophages on ac-tivation by cytokines. We have used serial pancreatic biopsy, and measurement of serum biopterin at 30,60,90 and 120 days in the BB/S rat to relate histological change to macrophage activation during the course of pre-diabetes. Using immunohistochemistry, and an arbi-trary scoring system read blind and standardised against day 30, we found that pancreatic MHC class I, MHC class II and infiltrating macrophage staining were up-regulated in the BB/S diabetes-prone rats (n = 17) at day 60, markedly so at day 90, and less so at day 120. Staining for resident pancreatic macrophages remained unchanged throughout in diabetes prone, diabetes resis-tant and Wistar (n = 28) control animals. Serum biop-terin fell progressively and identically with age in BB diabetes resistant rats (n = 11) and Wistar controls. No change in weight gain or biopterin levels was observed in the biopsied animals. Mean serum biopterin levels in diabetes prone rats (of which 13 of 17 became diabetic at median 85 days) were the same as in diabetes resistant and Wistar rats at days 30,60 and 120, but showed a strik-ing and highly significant elevation (p > 0.001) atday 90. Although macrophages infiltrate the islet early in pre-diabetes, the timing of their activation is unknown. The rise in biopterin we observed is a potentially important immunological event which occurred late in the pro-gression of pre-diabetes. This acute terminal event has not been reported previously, and may modify current concepts concerning the tempo of cell destruction during pre-diabetes.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Abbreviations
- BB:
-
Bio Breeding
- IDDM:
-
insulin-dependent diabetes mellitus
Reference
Mandrup-Poulsen T, Helquist S, Molvig J, Wogensen LD, Nerup J (1989) Cytokines as immune effector molecules in autoimmune endocrine diseases, with special reference to insulin-dependent diabetes mellitus. Autoimmunity 4: 191–218
Walker R, Bone AJ, Cooke A, Baird JD (1988) Distinct mac-rophage sub-populations in pancreases of pre-diabetic BB/E rats: possible role for macrophages in the pathogenesis of IDDM. Diabetes 37: 1301–1304
Kolb-Bachofen V, Kolb H (1989) A role for macrophages in the pathogenesis of type 1 diabetes. Autoimmunity 3: 145–154
Srikanta S, Ganda OP, Gleason RE, Jackson RA, Soeldner JS, Eisenbarth GS (1984) Pre-type 1 diabetes: linear loss of cell response to intravenous glucose. Diabetes 33: 717–720
Gamble DR (1969) Seasonal incidence of diabetes mellitus. BMJ 3: 631–633
McCulloch DK, K1aff LJ, Kohn SE et al. (1990) Non-progression of subclinical beta-cell dysfunction among first degree relatives of IDDM patients. Diabetes 39: 549–556
Karjalainen J, Martin JM, Knip M et al. (1992) Evidence for a bovine albumin peptide as a candidate trigger of type 1 diabetes. N Eng J Med 327:302–307
Huber Ch, Batchelor JR, Fuchs D et al. (1984) Immune-response associated production of neopterin. J Exp Med 160: 310–316
Wachter H, Fuchs D, Hansen A, Reibnegger G, Werner ER (1989) Neopterin as a marker for activation of cellular immunity: immunologic basis and clinical application. Adv Clin Chem 27: 81–141
Manna R, Gambassi G, Papa G (1987) Urinary neopterin levels of insulin dependent diabetes mellitus (IDDM) at onset. In: Pfleiderer W, Wachter H, Blair JA (eds) Biochem Clin Aspects Pteridines. de Gruyter, NY, pp 353–358
Bottazzo GF, Bonifacio E, Wagner R, al-Sakkaf L, Dean BM, Mirakian R (1990) Onthe pathogenesisoftype 1 (insulin-dependent) diabetes mellitus: facts, areas still under development and new perspectives. Klin Wochenschr 68 [Suppl 21]: 26–27
Maerker-Alzer G, Diemer O, Struemper R, Rohe M (1986) Neopterin production in inflamed knee joints: high levels in synovial fluids. Rheumatol Int 6: 151–154
Fuchs D, Hansen A, Reibnegger G, Werner ER, Dierich MP, Wachter H (1988) Neopterin as a marker for activated cell-mediated immunity. Immunol Today 9: 150–155
Tayeh MA, Marietta MA (1989) Macrophage oxidation of L-arginine to nitric oxide, nitrite and nitrate. J Biol Chem 264: 19654–19658
Corbett JA, McDaniel ML (1992) Does nitric oxide mediate autoimmune destruction of cells? Diabetes 41: 897–903
Kolb H, Kolb-Bachofen {GNV} (1992) Type 1 (insulin-dependent) diabetes mellitus and nitric oxide. Diabetologia 35: 796
Bone AJ, Walker R, Varey AM, Cooke A, Baird JD (1990) Effect of cyclosporine on pancreatic events and development of diabetes in BB/E rats. Diabetes 39: 508–514
Logothetopoulos J, Valequette N, Madura E, Cuet {GND} (1984) The onset and progression of pancreatic insulitis in the overt, spontaneously diabetic, young adult BB rat studied by pancreatic biopsy. Diabetes 33: 33–36
Dijkstra CD, Dopp EA, Joling P, Kraal G (1985) The heterogeneity of mononuclear phagocytes in lymphoid organs: distinct macrophage subpopulations in the rat recognised by monoclonal antibodies EDI, ED2 and ED3. Immunology 54: 589–599
Kroncke KD, Kolb-Bachofen V, Berschick B, Burkart V, Kolb H (1991) Activated macrophages kill pancreatic synge-neic islet cells via arginine-dependent nitric oxide generation. Biochem Biophys Res Commun 175: 752–758
Wogensen LD, Reimers J, Nerup J et al. (1992) Repetitive in-vitro treatment with human recombinant interleukin-1 modifies beta cell function in normal rats. Diabetologia 35: 331–339
Hanenberg H, Kolb-Bachofen V, Kantwerk-Funke G, Kolb H (1989) Macrophage infiltration precedes, and is a prerequisite for, lymphocytic insulitis in pancreatic islets of pre-diabetic BB rats. Diabetologia 32: 126–134
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Davies, A.J., Bone, A.J., Wilkin, T.J. et al. Serum biopterin — a novel marker for immune activation during pre-diabetes in the BB rat. Diabetologia 37, 466–470 (1994). https://doi.org/10.1007/s001250050133
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/s001250050133